A high level of clinical response is associated with improved patient-reported outcomes in psoriasis: analyses from a phase 2 study in patients treated with ixekizumab
2015 ◽
Vol 30
(5)
◽
pp. 864-865
◽
Keyword(s):
Phase 2
◽